Real-world effectiveness of IDegLira compared with intensified conventional insulin therapy in adults with type 2 diabetes: a retrospective cohort study.

Sándor Szépkúti Szilvia Bandur Gábor Kovács Tamás Ferenci Márk M SvébisPiroska TurbuczÁdám Gy Tabák

Published in: BMC endocrine disorders (2022)

Treatment with IDegLira over 18 months resulted in greater HbA1c reductions, weight loss versus gain, and a lower rate of hypoglycaemia versus ICT in people with type 2 diabetes.

Keyphrases

weight loss
type diabetes
randomized controlled trial
systematic review
bariatric surgery
glycemic control
roux en y gastric bypass
gastric bypass
combination therapy
body mass index
bone marrow